Informations:
Erreur:
ID
29317
Description
Peroxisome Proliferator-Activated Receptor-gamma (PPAR-gamma) Agonist in Diabetic End-Stage Renal Disease Patients; ODM derived from: https://clinicaltrials.gov/show/NCT00745914
Lien
https://clinicaltrials.gov/show/NCT00745914
Mots-clés
Versions (1)
- 18/03/2018 18/03/2018 -
Détendeur de droits
See clinicaltrials.gov
Téléchargé le
18 mars 2018
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Endstage Renal Disease NCT00745914
Eligibility Endstage Renal Disease NCT00745914
- StudyEvent: Eligibility
Similar models
Eligibility Endstage Renal Disease NCT00745914
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Diabetic end stage renal disease | Chronic peritoneal dialysis | Carotid Artery Plaque Ultrasonography | Carotid Intima-Media Thickness Focal
Item
diabetic esrd patients receiving long-term pd treatment, with carotid plaque (defined as focal intima-media thickening >1mm) present on screening ultrasonography
boolean
C0854078 (UMLS CUI [1])
C0455150 (UMLS CUI [2])
C0751633 (UMLS CUI [3,1])
C0041618 (UMLS CUI [3,2])
C1960466 (UMLS CUI [4,1])
C0205234 (UMLS CUI [4,2])
C0455150 (UMLS CUI [2])
C0751633 (UMLS CUI [3,1])
C0041618 (UMLS CUI [3,2])
C1960466 (UMLS CUI [4,1])
C0205234 (UMLS CUI [4,2])
Informed Consent
Item
patients who provide informed consent for the study
boolean
C0021430 (UMLS CUI [1])
Inflammatory disorder Systemic | Lupus Erythematosus, Systemic
Item
patients with systemic inflammatory disease such as systemic lupus erythematosus
boolean
C1290884 (UMLS CUI [1,1])
C0205373 (UMLS CUI [1,2])
C0024141 (UMLS CUI [2])
C0205373 (UMLS CUI [1,2])
C0024141 (UMLS CUI [2])
Chronic liver disease | Liver Cirrhosis
Item
patients with chronic liver disease or cirrhosis
boolean
C0341439 (UMLS CUI [1])
C0023890 (UMLS CUI [2])
C0023890 (UMLS CUI [2])
Malignant Neoplasms
Item
patients with current active malignancy
boolean
C0006826 (UMLS CUI [1])
Chronic rheumatic heart disease | Congenital heart disease
Item
patients with chronic rheumatic heart disease or congenital heart disease
boolean
C0175708 (UMLS CUI [1])
C0152021 (UMLS CUI [2])
C0152021 (UMLS CUI [2])
Reduced general condition
Item
patients with poor general condition
boolean
C1112627 (UMLS CUI [1])
Kidney Transplantation Living related Planned
Item
patients with plan for living related kidney transplant within coming 1 year
boolean
C0022671 (UMLS CUI [1,1])
C3841816 (UMLS CUI [1,2])
C1301732 (UMLS CUI [1,3])
C3841816 (UMLS CUI [1,2])
C1301732 (UMLS CUI [1,3])
Heart failure Pre-existing New York Heart Association Classification
Item
patients with pre-existing class iii/iv heart failure,
boolean
C0018801 (UMLS CUI [1,1])
C2347662 (UMLS CUI [1,2])
C1275491 (UMLS CUI [1,3])
C2347662 (UMLS CUI [1,2])
C1275491 (UMLS CUI [1,3])
Recurrent hypoglycemia
Item
patients with recurrent hypoglycemia
boolean
C1846288 (UMLS CUI [1])
Thiazolidinediones
Item
patients already on glitazone treatment
boolean
C1257987 (UMLS CUI [1])
Pregnancy
Item
female patients with pregnancy
boolean
C0032961 (UMLS CUI [1])
Medical contraindication Magnetic Resonance Imaging | Medical contraindication Artificial cardiac pacemaker | Medical contraindication Metallic implant
Item
patients with contraindications for mri examination including those with pacemaker or metallic implant.
boolean
C1301624 (UMLS CUI [1,1])
C0024485 (UMLS CUI [1,2])
C1301624 (UMLS CUI [2,1])
C0030163 (UMLS CUI [2,2])
C1301624 (UMLS CUI [3,1])
C3693688 (UMLS CUI [3,2])
C0024485 (UMLS CUI [1,2])
C1301624 (UMLS CUI [2,1])
C0030163 (UMLS CUI [2,2])
C1301624 (UMLS CUI [3,1])
C3693688 (UMLS CUI [3,2])